文献速递生殖医学

美国学术生育中心的女性生殖道结核筛查

Genital tuberculosis screening at an academic fertility center in the United States.
PubMed 文献 · Am J Obstet Gynecol · 2020-06-01

这项前瞻性队列研究纳入2014年1月至2017年1月就诊的323例不孕症患者,筛查潜伏性结核风险,高危者行QuantiFERON-TB Gold检测,阳性者进一步行子宫内膜活检、结核聚合酶链反应和抗酸分枝杆菌培养。25例(7.7%)QuantiFERON-TB Gold阳性,其中1例子宫内膜检测证实女性生殖道结核。

要点

  • 323例不孕症患者中25例(7.7%)QuantiFERON-TB Gold阳性。
  • QuantiFERON-TB Gold阳性者中外国出生者占92%,阴性者中占29%(P<.001)。
  • QuantiFERON-TB Gold阳性者复发性妊娠丢失发生率为28%,阴性者为7%(P=.003)。

核心结论

  • 美国不孕女性中女性生殖道结核的患病率似乎较低,但若不采用包括子宫内膜取样在内的多种诊断方法,可能被漏诊。
  • 鉴于接受辅助生殖技术的受累患者存在严重母儿并发症的潜在风险,作者建议对美国所有寻求不孕症治疗的高危女性筛查潜伏性结核。
  • 作者建议筛查阳性者在不孕症治疗开始前行子宫内膜活检,通过组织学、聚合酶链反应和结核分枝杆菌培养排除女性生殖道结核。

研究设计与样本

  • 前瞻性队列研究,纳入2014年1月至2017年1月在本学术生育中心就诊的所有不孕症评估患者。
  • 有潜伏性结核风险的患者接受QuantiFERON-TB Gold血清学检测筛查。
  • QuantiFERON-TB Gold阳性患者进一步行子宫内膜活检,包括临床病理学家组织病理学检查、结核聚合酶链反应和抗酸结核分枝杆菌培养。

主要发现

  • 323例不孕症患者中25例(7.7%)QuantiFERON-TB Gold阳性。
  • QuantiFERON-TB Gold阳性者中外国出生者占92%,阴性者中占29%(P<.001)。
  • QuantiFERON-TB Gold阳性者复发性妊娠丢失发生率为28%,阴性者为7%(P=.003)。
  • QuantiFERON-TB Gold阳性者Asherman综合征发生率为8%,阴性者为0.3%(P<.001)。
  • QuantiFERON-TB Gold阳性者中仅2例(8.0%)胸部X线异常;子宫内膜评估发现2例(8.0%)异常,其胸部X线正常,其中1例显示女性生殖道结核证据,表现为组织学符合慢性肉芽肿性子宫内膜炎,且子宫内膜结核聚合酶链反应、抗酸杆菌涂片和结核分枝杆菌培养均阳性。

临床怎么用

  • 作者建议对美国所有寻求不孕症治疗的高危女性筛查潜伏性结核。
  • 作者建议筛查阳性者在不孕症治疗开始前行子宫内膜活检,通过组织学、聚合酶链反应和结核分枝杆菌培养排除女性生殖道结核。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infertility is a common presentation of female genital tuberculosis in endemic areas. Female genital tuberculosis-related maternal and neonatal complications have increased in recent years after assisted reproductive technology treatments. Despite rising emigration rates to the United States, guidelines to identify those with latent tuberculosis or female genital tuberculosis in fertility centers do not exist. OBJECTIVE: This study aimed to characterize the prevalence of female genital tuberculosis in infertile patients at our academic fertility center. STUDY DESIGN: This is a prospective cohort study. All patients presenting for infertility evaluation between January 2014 and January 2017 were assessed for risk factors for latent tuberculosis. Patients at risk for latent tuberculosis underwent screening using QuantiFERON-TB Gold serum assay. QuantiFERON-TB Gold-positive patients underwent further testing for female genital tuberculosis consisting of endometrial biopsy with histopathologic examination by a clinical pathologist, polymerase chain reaction for tuberculosis, and culture for acid-fast Mycobacterium tuberculosis. RESULTS: Twenty-five of 323 infertility patients (7.7%) screened for latent tuberculosis had positive QuantiFERON-TB Gold results. A greater number of patients with a positive test result for QuantiFERON-TB Gold were foreign born than those with a negative test result for QuantiFERON-TB Gold (92% vs 29%; P<.001). Of note, the QuantiFERON-TB Gold-positive population had a higher incidence of both recurrent pregnancy loss (28% vs 7%; P=.003) and Asherman syndrome (8% vs 0.3%; P<.001). Among those with a positive test result for QuantiFERON-TB Gold, chest x-ray was abnormal in only 2 patients (8.0%). Endometrium evaluation revealed abnormalities in 2 patients (8.0%), in whom chest x-ray was normal, with 1 showing evidence of female genital tuberculosis. This was indicated by histology consistent with chronic granulomatous endometritis and positive endometrial testing for tuberculosis by polymerase chain reaction, acid-fast bacilli smear, and culture for Mycobacterium tuberculosis. CONCLUSION: Although the prevalence of female genital tuberculosis in infertile women in the United States seems to be low, this study indicates that it can be underdiagnosed without utilization of multiple diagnostic modalities including endometrial sampling. Given the potential for serious maternal and neonatal morbidity in affected patients utilizing assisted reproductive technology, we propose that all at-risk women seeking infertility care in the United States be screened for latent tuberculosis. In patients who screen positive, endometrial biopsy should be obtained for evaluation by histology, polymerase chain reaction, and culture for Mycobacterium tuberculosis to rule out female genital tuberculosis before infertility treatments are initiated.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Tal R, Lawal T, Granger E, et al. Genital tuberculosis screening at an academic fertility center in the United States. Am J Obstet Gynecol. 2020. PMID: 32497612. doi:10.1016/j.ajog.2020.05.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。